Who are Ascendis Pharma A/S's main suppliers?

Ascendis Pharma A/S (ASND) key suppliers include: VISEN-PHARMACEUTICALS, TEIJIN-LIMITED, OPKO Health, Inc.. View the full supplier network at chainsifter.com/chain/ASND.

Who are Ascendis Pharma A/S's major customers?

Ascendis Pharma A/S (ASND) key customers include: Werewolf Therapeutics, Inc., OPKO Health, Inc.. View the full customer network at chainsifter.com/chain/ASND.

What sector is Ascendis Pharma A/S in?

Ascendis Pharma A/S (ASND) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

ASND Supply Chain: Ascendis Pharma A/S Supplier List & 6 Relationships

3Suppliers

2Customers

1Debt Items

20Related Chains

Ascendis Pharma A/S Suppliers

Ticker	Name	Confidence	Evidence
VISEN-PHARMACEUTICALS	VISEN-PHARMACEUTICALS	90%	In connection with the formation of VISEN, we granted VISEN exclusive rights to develop and commercialize our rare disease endocrinology products based on our proprietary TransCon technologies
TEIJIN-LIMITED	TEIJIN-LIMITED	85%	we entered into an exclusive license agreement with Teijin Limited, to develop and commercialize Tr
OPK	OPKO Health, Inc.	72%	Reciprocal relationship from OPK graph: aboratories, molecular diagnostic firms, universities and research institutions. Most of these companies have substantially greater financial and other resourc…

Ascendis Pharma A/S Customers

Ticker	Name	Confidence	Evidence
HOWL	Werewolf Therapeutics, Inc.	72%	Reciprocal relationship from HOWL graph: Reciprocal relationship from ASND graph: Reciprocal relationship from HOWL graph: Reciprocal relationship from ASND graph: Reciprocal relationship from HOWL g…
OPK	OPKO Health, Inc.	72%	Reciprocal relationship from OPK graph: aboratories, molecular diagnostic firms, universities and research institutions. Most of these companies have substantially greater financial and other resourc…

Ascendis Pharma A/S Debt Obligations

Instrument	Description	Confidence	Evidence
ASND-DEBT	Debt stack $1.0B	90%	Market cache reports total debt of $1.0B.

Ascendis Pharma A/S Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Ascendis Pharma A/S.

Ascendis Pharma A/S Ownership

Holder	Name	Confidence	Evidence
ASND-OWNER-RA-CAPITAL-MANAGEMENT-L-P	RA CAPITAL MANAGEMENT, L.P.	90%	13F overlay lists RA CAPITAL MANAGEMENT, L.P. as top holder; 273 tracked holders.

Ascendis Pharma A/S Extended Supply Chain Network

Ticker	Name	Chain Index	Hops
EDIT	Editas Medicine, Inc.	100.00	2
ATOS	Atossa Therapeutics, Inc.	100.00	2
BLRX	BioLineRx Ltd.	100.00	2
DBVTF	DBV TECHNOLOGIES	100.00	2
ANL	Adlai Nortye Ltd.	100.00	2
CUE	Cue Biopharma, Inc.	100.00	2
CRBP	Corbus Pharmaceuticals Holdings, Inc.	100.00	2
WHWK	Whitehawk Therapeutics, Inc.	100.00	2
CTMX	CytomX Therapeutics, Inc.	100.00	2
BIOA	BioAge Labs, Inc.	100.00	2
CYTK	Cytokinetics, Incorporated	100.00	2
CBIO	Crescent Biopharma, Inc.	100.00	2
ANRO	Alto Neuroscience, Inc.	100.00	2
ALXO	ALX Oncology Holdings Inc.	100.00	2
CCEP	Coca-Cola Europacific Partners PLC	100.00	2
DSGN	Design Therapeutics, Inc.	100.00	2
AZN	AstraZeneca PLC	100.00	2
CYTOF	Altamira Therapeutics Ltd.	100.00	2
CANF	Can-Fite BioPharma Ltd.	100.00	2
REGN	Regeneron Pharmaceuticals, Inc.	100.00	2

Ascendis Pharma A/S Supply Chain